Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.

We have previously described the generation of a novel Ebola virus (EBOV) vaccine platform based on (a) replication-competent rabies virus (RABV), (b) replication-deficient RABV, or (c) chemically inactivated RABV expressing EBOV glycoprotein (GP). Mouse studies demonstrated safety, immunogenicity,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Joseph E Blaney, Andrea Marzi, Mallory Willet, Amy B Papaneri, Christoph Wirblich, Friederike Feldmann, Michael Holbrook, Peter Jahrling, Heinz Feldmann, Matthias J Schnell
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2013
Sujets:
Accès en ligne:https://doaj.org/article/60fe6f225613448a9bacf31d5f5b2477
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!